Incont Pelvic Floor Dysfunct 2007; 1 (Suppl 1):3-6

Differential Diagnosis of Male Lower Urinary Tract Symptoms

Suggestive of Benign Prostatic Hyperplasia and Non-Benign
Prostatic Hyperplasia

Hann-Chorng Kuo, M.D.

Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan

fkqolar`qflk =~=~~==~=irqpK

i=~=~==EirqpF==~= ^ppbppjbkq=lc=j^ib=irqp
E~=~=~I=I=I==
~=~FI===E~I=~I=I ^==~=irqp==~=J~=
=~I=~==~=~==~F=~=~ =~==~==^~=r~=^~=E^r^F
=E=~I=~=~=~=~=~FK=irqp=~= ==~=f~~=m~=p=p=EfmppF=xVzK
~===~=I=~=~==~=xNzK=irqp=~ ^==~=======~=
=~===~=~==~==J ===~====~=~==~
===~=~~=E_meFK=eI==~= ~=El^_F==~=K=r=~==J
~=~==ORB==RMB====_me=~=irqp=~= ~==EmsoFI=~=~==~=~=~J
RMB====irqp=~=~~==~==J ~=EaobFI=~~==~~~=~=~=~~~
=E_llF===_me===~==xOzK ~=~==~===~=~=
K=f===~===~=~=I=~
mobs^ibk`b=lc=j^ib=irqp ~=~~==~I==~=~=I
~=~=~=~=~~==~K
q=~=~===irqp=~==~I=~= `I=~==~=EbjdF=~=
=~===~=~=~=~==J ======~===~J
~===~===irqp=xPzK=^=irqpI=~J ====~==~K=`=~=~
=~=~==~=====I=~=~ ====~==~====~
~=~X====~=~==~=~ K=^==~=~I=~=~==irqp=~=
=xQzK=^==~=~==~I=I= ~==irqp===_meI=irqp===alI=J
=~=~==~=~=I==J =~===~=K=m~==~=~
=======xRzK=f=~=~ ~====~=_ll==~=K
==~=q~~I=~=E[O===F=~==
=irqp==~=~=J~I==~=~ irqp=fk=_ll
~==PNKNB=~=NVKUBI=K=^=NRB===
=irqp=~=~=~=~===~===xSzK _ll==~=~=====~==J
=~L===~K=m~===irqp=E~=~L
m^qelmevpflildv=lc=j^ib=irqp =irqpF==_ll=~===~=~=K
_ll=~====~=I==~=~=I=~=
q=~==irqp===~= ~~~=~==K=f=~==~=
E~=I==~=EalFFI=_ll=E~ =_ll=~=irqpI==~==~=En~F=~==
=I=~=I=~=I==J OM=iL==~=~====OVM=i=Eq~=NFK=l==
~=~=I=~==~F==~=J ==irqp===~=_llK=j~=~==~=J
~====xTzK=j~==~==~=~=J ~=~=irqp=~=~==~===_ll=~=RBJ
=K=f=I===~=== PRB==~==_me=~=irqp===~==
~==~=~===xUzK=c ~=~~====~=EqromF=xNMzK=q=~
==~=~=~=====~J =~==~==~==~=~=
~==~K
Received: January 31, 2007 Accepted: February 28, 2007 `~=_me===~=~=~=~====W=ENF
Address correspondence to: Dr. Hann-Chorng Kuo, Department of Urology, Buddhist
~===irqp=Efmpp UFI=EOF=~=~=~=E~
Tzu Chi General Hospital, 707, Section 3, Chung Yang Road, Hualien, Taiwan
E-mail: hck@tzuchi.com.tw ~==EqmsF= PM=iF=~=EPF=~=n~=EYNR=iLF

P
H. C. Kuo

Table 1. Normal Uroflow rate in Taiwanese Men by Age

Age years Qmax (mL/S) Voided volume (mL) CQmax

45 23.98.73 (127) 339.8191.1 1.410.51

46-55 19.76.81 ( 68) 305.4159.2 1.210.42
56-65 20.26.20 (134) 286.8138.8 1.270.42
66-75 19.26.10 (143) 262.8109.3 1.230.39
76-85 18.77.50 ( 42) 225.3101.5 1.310.47

All ages 20.77.30 (514) 290.7123.2 (514) 1.290.45 (514)

Table 2. Differential Diagnosis of Male LUTS/BOO & Non-BOO ~==~=~=====[PRM=i=

Badder neck dysfunction

Bladder hypersensitivity

Overactive bladder

Spastic urethral sphincter

Poor relaxation of urethral sphincter

Urethral stricture

Low detrusor contractility

Pseudodyssynergia due to neuropathy
xNNzK=^=~=~=~===~===
_llI==~=qms==~==_ll==~==~
~==~==_ll=xNOzK=f=~I=~==irqp=J
==_me=~==~=n~==YNM=iL=~=~=~=J
==n~=~=qrom=~====~=n~==[NM
iLK=m~====_ll=~=~=~=~
==~=qrom=xNPzK=m~==~=irqp=~
==~=~=~=qms=~====I==~=~
J_me===~===irqp=xNQzK=qI=~J
==~=_me===~=~I=~=
~=~===~=qrom=====K=q
~=~==J_me=irqp====q~=OK
irqp=fk=klkJ_me=`lkafqflkp
Bladder hypersensitivity
^==~===irqp===J_me=I
~==~=al=~==I=~=
=K=p==~======~J
==alI==~~==~=I=~=I =I===~=~==~=
_ll====K=o=~=~
=~==~=~==~I==~=~J
=E^FI=~=~=E^qmF=~==
~=mI=~====qomsN=~=mOuP==
=~======~=~=~~
xNRINSzK=q=~==~=^=~==^qm=
~==~K=q=~=~=~==
~=~==~==~=l^_I=~=~=
======~=~=~
~=Eaef`F====xNTzK
Polyuria
^===~=~=~=~=~====
OUMM=iL~K=m~=~=~=~=~==~=~I
~====~=~=xNUzK=eI===~I
====~=~I==~I=~~I
~I==~=~==~~=K
Psychological factors
^===~I=~==~=~
~==~===~=~K=q=~=~=~
~=====~=~====~K=q==~
==~====K=q=~=~====~
~====~=~==~=~I
==~K
Urothelial dysfunction
p====J====J
=====~=~=I==~==K
m~=~=~=====~===~
~======~==~=I=
~==~=~=K=q===~~==
=~==~=~====~=l^_=
=xNVzK=f~=qomsN===~===
=====~==~=EfalFI=~
~=~=~=~=====^=E_quJ^F=
==~======~J
==~=~=~=~=~=~=xOMzK
m~==~==~===
=~==~==~~K=r==I=J
~~=~=~==~=_quJ^==
====~==l^_=K=f~=
=~=EkdcF==~====~==
===xONzK=f~=~==~=kdc=J
===I==~==~==I
=~Jkdc=~=~==~~==~==J
=K=f~~=_quJ^=~====~=J
==al=~=~==~~=E`f`FI=~==J
==kdc=~=====~=_quJ^=~=
~====~=EkalFI=fal==`f`
E=~~FK
Overactive bladder
o=~==~=irqp==~=~=J
=~=~=~===~==_llK=irqp==
l^_=~==~=====NSB====b
~==r=p~=xNzK=^=~~=~=~==~

Q
 Differential diagnosis of male LUTS

~=VMB===~=RM==UM=~===~=J _ml=~==~=~=~=~=~=~K=^=~=J
=irqpI=~=~==~==~=~== ==~==~======I=
xOOzK=l^_====~==~=~=irqp ~I=~=~===~~=~~K=q~J
=_me=~==~=~==~K=p=== ==~======~=~===~==
l^_====I===~=irqp=~=J ~=~===~=K=a~=~=~~=EaobF
=~==~=_me=xOPzK=eI=~=irqp=J ~= ~= ~~= = ~~= = ~= I
~===_ll=~=~=l^_==~==~= ===~=I===~
~===~=al==aef`I====~= ~===~====~~===~
_ll=xTzK=eI=~==~===QRBJRMB== ~==~==~===K
=irqp=~=~~==al=~=_ll=xOIOQzK q~~==~~===~=~==J
al=~====~==~I==~ ~=====irqp=~=~=~=K=`~~J
I=J=alI==~===aef`K=f= =~=~=~~=~==
=irqpI====_ll=K=f=~=====~J ~=~==~===K=eI=
==~=irqpI==OVKQB===~==~ J=~==~=~=~==`luJO=J
=E_mlF=~=RNKNB==~=irqp=~===al=E =~====I=~=I==
~~FK=^==~==_mlI=UMKVB===~=alK=eI ~=~=~=~==~=~====
~==~==~=alI==QUB===~ ~=~=~~K
~=_mlK=m~==_ml===l^_==
===l^_=~=qromI==~=== Post-prostatectomy male LUTS
=~==~==l^_=xORzK=q~==~= l=~===~==J~=irqp=~=~
_ml=~=l^_===~=~==~=~ ~=~=~==~==~~=I=~
~==~=~~===l^_==~==J =irqp==J_me==J_ll===qromK=^
==~==~=~~J===R=~~JJ ~==J~=irqpI=~=~=~=~
~=K ~===VKNBI=al==VKSBI==~==NUKTBI=
~=~===NVKPBI=aef`==NQKQB=~=~=_ll
Nocturia and nocturnal polyuria =OTKUB=xNQzK=a~==~=~==~
irqp=~=====~=~==== ~===~I=~===~=~=
=irqpK=q=~==~=~==UMB= ~=~=_me==_ll=~=~===~=~~
~=~==UM=~K=k~=======~ K=^=~=~====~==J
===~===K=q=~==~=J ===J~=irqpK=aef`I=~=
=alI==~I=_llI=~=~==~ =l^_=~=~==~==~=irqp=====~=~
~=~~K=t==~===[VMM=i== _meK
~=PRB===~==I=~=~==K=i~
=~===~=~=~=~=~=~ Other conditions
=~=====~=aa^sm=xOSzK=f r~==~==~==
~I==~===~=~=~=_ll= I=~~~=I=m~D=~==
l^_I===~==~====J ~=~====~=====xOUzK
=~=irqpK q=~==~=_me===irqp=~=~==J
==~=_meK=p~====_ll==~~
Poor relaxation of the urethral sphincter ===~===~=~=irqp=J
^==~=~==J_ll=~=irqpI==~~J ~=irqp=~=~=====K=rJ
===~=======J ~===~=~~==~=~=_ll=~=irqpI
=xOTzK=m~==~===~I=I ~==~==~=~=~==~~=K
=~===K=p=~==~=~=J ^=~=~=~~=~=~=~J~=~==
~===~===K=q=~===J irqp==~=~=~=~=K
~~===~====~=~I=
~I===I==~==~ `lk`irpflkp
~=K=^=====~=~=~
I====~=~=~=~===~==I irqp===~==~===~==~
~= = ~= = ~K= a~= ~= = ~= ~==I==~===~K=q
I==bjd===~== ===~=irqp=~=~==~===J
K =_mlK=j~=~==_ll=~=~==~K=_
~I==~==~==~==al=~
Pain symptoms aef`I=~==~==~==~====~
p~==~=~=~===K=f~ ~===~=_mlK=_~==~==J
I=_llI==~=~=~=~~==~~ ~=~=====alK=irqp======J
~=~=~=~=~K=r~=~=I=~=I ~=~==_ml==J_ml==K=q====l^_I

R
H. C. Kuo
KK=I=~====~=~==~==alK=q static hyperplasia and lower urinary tract symptoms. JUTA 2006;
==irqp=~===~==~=~ 17:41-47.
=K=^~=~===~=~=J 13. Kuo HC, Tsai TC: Assessment of prostatic obstruction and bladder
===~==~==~=I=
=~====~=~=~==~=~==J 14. Kuo HC: Analysis of pathophysiology of the lower urinary tract symp-
=~K toms in patients after prostatectomy. Urol Int 2002; 68: 99-104.
obcbobk`bp
1. Milson I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ:
How widespread are the symptoms of an overactive bladder and
how are they managed? A population based prevalence study. BJU
Int 2001; 87:760-766.
2. Eckhardt MD, van Venrooij GE, Boon TA: Symptoms, prostate
volume, and urodynamic findings in elderly male volunteers without
and with LUTS and in patients with LUTS suggestive of benign pro-
static hyperplasia. Urology 2001; 58:966- 971.
3. Engstrom G, Henningsohn L, Steineck G, Leppert J: Self-assessed
health, sadness and happiness in relation to the total burden of
symptoms from the lower urinary tract. BJU Int 2005; 95:810-815.
4. Jackson S: Lower urinary tract symptoms and nocturia in men and
women: Prevalence, aetiology and diagnosis. BJU Int 1999; 84
(Suppl 1):5-8.
5. Abrams P, Cardozo L, Fall M, et al: The standardization of terminol-
ogy of lower urinary tract function: Report from the Standardisation
Subcommittee of the International Continence Society. Neurourol
Urodyn 2002; 21:167-181.
6. Ke Qian-Sheng, Kuo HC: Prevalence of lower urinary tract symp-
toms in aborigines and non-aborigines in eastern Taiwan.
(unpublished data)
7. Kuo HC: Pathophysiology of lower urinary tract symptoms in aged
men without bladder outlet obstruction. Urol Int 2000; 64:86-92.
8. Peters TJ, Donovan JL, Kay HE, et al: The International Continence
Society "Benign Prostatic Hyperplasia Study: The bothersomeness
of urinary symptoms. J Urol 1997; 157:885-889.
9. Cockett A, Aso Y, Denis L, et al: Recommendation of the Interna-
tional Consensus Committee concerning: 1. Prostate symptom score
and quality of life assessment. In: Cockett ATK, Khoury S, eds.
Proceedings, The 2nd International Consultation on Benign Pros-
tatic Hyperplasia (BPH), Paris, June 27-30, 1993. Jersey: Channel
Island, Scientific Communication International Ltd, 1994, pp 553-
555.
10. Neal DE, Ramsden PD, Sharples L, et al: Outcome of elective
prostatectomy. BMJ 1989; 299:762-767.
11. McConnell JD, Roehrborn CG, Bautista OM, et al, for the Medical
Therapy of Prostatic Symptoms (MTOPS) Research Group: The
long-term effect of doxazosin, finasteride, and combination therapy
on the clinical progression of benign prostatic hyperplasia. N Eng J
Med 2003; 349:2387-2398.
12. Chen JL, Kuo HC: Implications of prostatic volume measurements
on the degree of bladder outlet obstruction in men with benign pro-
function by urodynamic pressure flow study. J Formosan Med Assoc
1987; 86:1084-1092.
15. Sun Y, Chai TC: Up-regulation of P2X3 receptor during stretch of
bladder Urothelial cells from patients with interstitial cystitis. J Urol
2004; 171:448-452.
16. Apostolidis A, Brady CM, Yiangou Y, Davis J, Fowler CJ, Anand P:
Capsaicin receptor TRPV1 in urothelium of neurogenic human blad-
ders and the effect of intravesical resiniferatoxin. Urology 2005; 65:
400-405.
17. Yoshida M, Miyamae K, Iwashida H, Otani M, Inadome A: Manage-
ment of detrusor dysfunction in the elderly: Changes in acetylcho-
line and adenosine triphosphate release during ageing. Urology
2004; 63:17-23.
18. Weiss JP, Stember DS, Blaivas JG, Brooks MM: Nocturia in adults:
Classification and etiology. Neurourol Urodyn 1998; 17:467-472.
19. Yucel S, Baskin LS: An anatomical description of the male and fe-
male urethral sphincter complex. J Urol 2004; 171:1890-1897.
20. Zermann DH, Ishigooka M, Schubert J, et al: Trigonum and bladder
base injection of botulinum toxin A (BTX) in patients with severe
urgency-frequency-syndrome refractory to conservative medical
treatment and electrical stimulation. Neurourol Urodyn 2001; 20:
412-413.
21. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi
DV, Osborne JL: Increased nerve growth factor levels in the urinary
bladder of women with idiopathic sensory urgency and interstitial
cystitis. Br J Urol 1997; 79:572-577.
22. Rosen R, Altwein J, Boyle P, et al: Lower urinary tract symptoms
and male sexual dysfunction: The Multinational Survey of the Age-
ing Male (MSAM-7). Eur Urol 2003; 44:637-649.
23. Temml C, Heidler S, Ponholzer A, Madersbacher S: Prevalence of
the overactive bladder syndrome by applying the International Con-
tinence Society definition. Eur Urol 2005; 48: 622-627.
24. Laniado ME, Ockrim JL, Marronaro A, Tubaro A, Carter SS: Serum
prostate-specific antigen to predict the presence of bladder outlet
obstruction in men with urinary symptoms. BJU Int 2004; 94:1283-
1286.
25. Thomas AW, Cannon A, Bartlett E, Ellis-Jonse J, Abrams P: The
natural history of lower urinary tract dysfunction in men: minimum
10-year urodynamic followup of transurethral resection of prostate
for bladder outlet obstruction. J Urol 2005; 174:1887-1891.
26. Kuo HC: Efficacy of desmopressin in the treatment of refractory
nocturia in the patients aged over 65 years. Urology 2002; 59:485-
489.
27. Kuo HC: Pathophysiology of lower urinary tract symptoms in aged
men without bladder outlet obstruction. Urol Int 2000; 64:86-92.
28. Ahlberg J, Edlund C, Wikkelso C, Rosengren L, Fall M: Neurologi-
cal signs are common in patients with urodynamically verified" idio-
pathic" bladder overactivity. Neurourol Urodyn 2002; 21:65-70.